Unbound MEDLINE

Anticoagulants and antiplatelet agents and the risk of development and recurrence of chronic subdural haematomas. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia [J Clin Neurosci] Journal article

 
TitleAnticoagulants and antiplatelet agents and the risk of development and recurrence of chronic subdural haematomas.
Author(s)Lindvall P, Koskinen LO 
InstitutionDepartment of Neurosurgery, Umea University Hospital, Umeå 901 85, Sweden.
SourceJ Clin Neurosci 2009 Jun 27.
AbstractSeventy-one patients from northern Sweden were diagnosed with chronic subdural haematomas (CSDH) and treated at the Department of Neurosurgery at Umeå University Hospital over 12months. Fifty-four patients with CSDH had a history of head trauma (trauma group), while 17 patients had no previous head trauma (non-trauma group). In the non-trauma group 71% of patients were treated with anticoagulants or antiplatelet aggregation agents (AAA) compared to 18% in the trauma group. Considering only AAA, 59% of the non-trauma patients were treated with these drugs versus 17% of patients in the trauma group. The recurrence rate for all patients was 17%. These findings confirm that the use of anticoagulants and AAA is over-represented in patients with non-traumatic CSDH. In our study, recurrence was not associated with previous use of anticoagulants or AAA.
LanguageENG
Pub Type(s)JOURNAL ARTICLE
PubMed ID19564115
  
Advertise on this site.